Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05820919 · ClinicalTrials.gov registry record · NA

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

A NA study of Alzheimer Disease and Dementia, sponsored by University of Alabama, Tuscaloo.

Recruiting
Registry status
NA
Development phase
456
Enrollment target
3
Study locations

NCT05820919 is a NA study of Alzheimer Disease and Dementia that is actively recruiting participants, run by University of Alabama, Tuscaloo. The registered enrollment target is 456 participants, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (83% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05820919, a NA study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by University of Alabama, Tuscaloo.

RECRUITING
Registry status
NA
Development phase
456 participants
Enrollment target
3
Study locations

Study Summary

This study seeks to improve clinical outcomes for an important, growing, and vulnerable population-nursing home residents with Alzheimer's disease or related dementias-by testing an evidence-based intervention to improve these residents' sleep. It will also examine the implementation and sustainment of this intervention.

Conditions Studied

Alzheimer Disease Dementia Sleep Disturbance Sleep Disorder

Interventions

  • BEHAVIORAL LOCK Sleep Program
  • OTHER No intervention (control period/baseline data collection)

Study Locations (3)

Colorado

  • Vivage/Beecan Corporation - Lakewood

Tennessee

  • National HealthCare Corporation - Murfreesboro

Texas

  • Caraday Healthcare, LLC - San Marcos

Trial Details

FieldValue
Enrollment Target 456 participants
Start Date 2023-09-07
Est. Completion 2027-05-29
Phase NA

Sponsor

University of Alabama, Tuscaloo

17 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05820919

The ClinicalTrials.gov registry entry for NCT05820919 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 456 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (83% lower). The listed sponsor is University of Alabama, Tuscaloo, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which LOCK Sleep Program is the first listed.

NCT05820919 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Colorado, Tennessee, Texas.

Frequently Asked Questions

What is clinical trial NCT05820919 about?

NCT05820919 is a clinical study titled "Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase". This study seeks to improve clinical outcomes for an important, growing, and vulnerable population-nursing home residents with Alzheimer's disease or related dementias-by testing an evidence-based intervention to improve these residents' sleep. It will also examine the implementation and sustainment...

What is the current status of trial NCT05820919?

This trial is currently recruiting. It is a NA study. The enrollment target is 456 participants. The study started on 2023-09-07. Estimated completion is 2027-05-29.

What conditions does trial NCT05820919 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Sleep Disturbance, Sleep Disorder.

What interventions are being tested in trial NCT05820919?

The interventions under investigation include: LOCK Sleep Program (BEHAVIORAL), No intervention (control period/baseline data collection) (OTHER).

Who is sponsoring clinical trial NCT05820919?

This trial is sponsored by University of Alabama, Tuscaloo, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05820919 being conducted?

This trial has 3 study locations across Colorado, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Dementia

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.